References
- Bi Z, Formenty PB, Roth CE. Hantavirus infection: a review and global update. J Infect Dev Ctries. 2008;2:3–23.
- McCaughey C, Hart CA. Hantaviruses. J Med Microbiol. 2000;49: 587–599.
- Butler JC, Peters CJ. Hantaviruses and hantavirus pulmonary syndrome. Clin Infect Dis. 1994;19:387–394; quiz 95.
- Jonsson CB, Figueiredo LT, Vapalahti O. A global perspective on hantavirus ecology, epidemiology, and disease. Clin Microbiol Rev. 2010;23:412–441.
- Hu W, Mengersen K, Bi P, Tong S. Time-series analysis of the risk factors for haemorrhagic fever with renal syndrome: comparison of statistical models. Epidemiol Infect. 2007;135:245–252.
- Zuo SQ, Fang LQ, Zhan L, et al. Geo-spatial hotspots of hemorrhagic fever with renal syndrome and genetic characterization of Seoul variants in Beijing, China. PLoS Negl Trop Dis. 2011;5:e945.
- Fang LQ, Wang XJ, Liang S, et al. Spatiotemporal trends and climatic factors of hemorrhagic fever with renal syndrome epidemic in Shandong Province, China. PLoS Negl Trop Dis. 2010;4:e789.
- Ma C, Wang Z, Li S, et al. Analysis of an outbreak of hemorrhagic fever with renal syndrome in college students in Xi'an, China. Viruses. 2014;29:507–515.
- Huang LY, Zhou H, Yin WW, et al. The current epidemic situation and surveillance regarding hemorrhagic fever with renal syndrome in China, 2010. Zhong Hua Liu Xing Bing Xue Za Zhi. 2012;33:685–691 (in Chinese).
- Luo CW, Chen HX. Epidemiological characteristics and the strategy of vaccination on hemorrhagic fever with renal syndrome in the last 10 years, in China. Zhonghua Liu Xing Bing Xue Za Zhi. 2008;29: 1017–1019 (in Chinese).
- National Pharmacopoeia Committee: Pharmacopoeia of the People’s Republic of China, third division, 2005 edn. China Chemical Industry Press; 2005, p 80–88.
- Chen GX, Liu S. Survey on specificity antibody against hemorrhagic fever with renal syndrome. Zhong Guo Mei Jie Sheng Wu Xu Ji Kong Zhi Za Zhi. 2002;13:210 (in Chinese).
- Boudreau EF, Josleyn M, Ullman D, et al. A Phase 1 clinical trial of Hantaan virus and Puumala virus M-segment DNA vaccines for hemorrhagic fever with renal syndrome. Vaccine. 2012;30:1951–1958.
- Zhang YZ, Zou Y, Fu ZF, Plyusnin A. Hantavirus infections in humans and animals, China. Emerg Infect Dis. 2010;16:1195–1203.
- Qin L, Gilbert PB, Corey L, et al. A framework for assessing immunological correlates of protection in vaccine trials. J Infect Dis. 2007;196:1304–1312.
- Rahier JF, Moutschen M, Van Gompel A, et al. Vaccinations in patients with immune-mediated inflammatory diseases. Rheumatology (Oxford). 2010;49:1815–1827.
- Dong GM, Han L, An Q, et al. Immunization effect of purified bivalent vaccine to haemorrhagic fever with renal syndrome manufactured from primary cultured hamster kidney cells. Chin Med J (Engl). 2005;118:766–768.
- Liu HN, Gao LD, Chowell G, et al. Time-specific ecologic niche models forecast the risk of hemorrhagic fever with renal syndrome in Dongting Lake district, China, 2005–2010. PLoS One. 2014;9:e106839.